Showing results (121-130 of 186) with videos related to
Sort By:
Pageof 19
ESMO Open|June 25, 2019
Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumabG Mountzios, Vassiliki Kotoula, Georgia-Angeliki Kolliou, et al.Cancer Genomics & Proteomics|April 26, 2019
Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast CancerGeorgios Lazaridis, Vassiliki Kotoula, Eleni Vrettou, et al.Clinical Breast Cancer|December 15, 2018
Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient OutcomeVassiliki Kotoula, Kalliopi Tsakiri, Georgia-Angeliki Koliou, et al.Journal of Translational Medicine|May 18, 2016
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancerHelen Gogas, Vassiliki Kotoula, Zoi Alexopoulou, et al.Cancer Genomics & Proteomics|February 29, 2020
Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast CancerAdamantia Nikolaidi, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.ESMO Open|November 2, 2019
Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)George Zarkavelis, Vassiliki Kotoula, Georgia-Angeliki Kolliou, et al.Clinical Colorectal Cancer|September 21, 2013
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximabAlexios Strimpakos, George Pentheroudakis, Vassiliki Kotoula, et al.Cancer Chemotherapy and Pharmacology|May 8, 2015
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patientsAnna Koumarianou, Georgia Karayannopoulou, Georgia Gourgioti, et al.Frontiers in Oncology|June 18, 2021
Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?Elena Fountzilas, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.Journal of Translational Medicine|May 30, 2015
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation studyAngelos Koutras, Konstantine T Kalogeras, Ralph M Wirtz, et al.Pageof 19